Chapter 1: The management of erectile dysfunction: an AUA update.
Montague
Drogo K
DK
Jarow
Jonathan P
JP
Broderick
Gregory A
GA
Dmochowski
Roger R
RR
Heaton
Jeremy P W
JP
Lue
Tom F
TF
Milbank
Aaron J
AJ
Nehra
Ajay
A
Sharlip
Ira D
ID
D015106:3',5'-Cyclic-GMP Phosphodiesterases; D035843:Biomedical Research / Q000639:trends; D054706:Cyclic Nucleotide Phosphodiesterases, Type 5; D007172:Erectile Dysfunction / Q000150:complications / Q000175:diagnosis* / Q000628:therapy*; D005544:Forecasting; D006801:Humans; D008297:Male; D015917:Penile Prosthesis; D010726:Phosphodiesterase Inhibitors / Q000627:therapeutic use; D010727:Phosphoric Diester Hydrolases; D014656:Vascular Surgical Procedures
D010726:Phosphodiesterase Inhibitors; D010727:Phosphoric Diester Hydrolases; D015106:3',5'-Cyclic-GMP Phosphodiesterases; D054706:Cyclic Nucleotide Phosphodiesterases, Type 5; C517381:PDE5A protein, human